Australia Nanomedicine Market Size & Outlook, 2024-2030
Related Markets
Australia nanomedicine market highlights
- The Australia nanomedicine market generated a revenue of USD 2,959.2 million in 2023 and is expected to reach USD 5,852.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 10.2% from 2024 to 2030.
- In terms of segment, drug delivery was the largest revenue generating application in 2023.
- Therapeutics is the most lucrative application segment registering the fastest growth during the forecast period.
Nanomedicine market data book summary
| Market revenue in 2023 | USD 2,959.2 million |
| Market revenue in 2030 | USD 5,852.8 million |
| Growth rate | 10.2% (CAGR from 2024 to 2030) |
| Largest segment | Drug delivery |
| Fastest growing segment | Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Delivery, Therapeutics, In-vitro Diagnostics, Implants, In-vivo Imaging |
| Key market players worldwide | Abbott Laboratories, Invitae Corp, Celgene, GE HealthCare Technologies Inc Common Stock, Johnson & Johnson, Mallinckrodt PLC Ordinary Shares - New, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Arrowhead Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 1.6% of the global nanomedicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China nanomedicine market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 23,032.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nanomedicine Market Scope
Nanomedicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc | View profile | 525 | 177 E. Colorado Boulevard, Suite 700, Pasadena, CA, United States, 91105 | https://www.arrowheadpharma.com |
| Celgene | View profile | 10001+ | Summit, New Jersey, United States, North America | https://www.bms.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | https://www.mallinckrodt.com |
| Invitae Corp | View profile | 1700 | 1400 16th Street, San Francisco, CA, United States, 94103 | https://www.invitae.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Australia nanomedicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nanomedicine market will help companies and investors design strategic landscapes.
Drug delivery was the largest segment with a revenue share of 34.13% in 2023. Horizon Databook has segmented the Australia nanomedicine market based on drug delivery, therapeutics, in-vitro diagnostics, implants, in-vivo imaging covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia nanomedicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia nanomedicine market databook
-
Our clientele includes a mix of nanomedicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia nanomedicine market , including forecasts for subscribers. This country databook contains high-level insights into Australia nanomedicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia nanomedicine market size, by application, 2018-2030 (US$M)
Australia Nanomedicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
